
Company Info
Year Established2023
Contacts
Andrew Thomson, MBACEO
Company Description
Modulate Bio's platform enables the development of novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, anxiety and more.